Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled, Open Labeled, Two Arm, Study of Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

NCT05833815 is registered in ClinicalTrials.gov with Banaras Hindu University as lead sponsor.

NCT NCT05833815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05833815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled, Open Labeled, Two Arm, Study of Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
Lead sponsor
Banaras Hindu University
Phase
Phase 2/3
Overall status
Recruiting
Start date
November 1, 2022
Completion date
December 30, 2024
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gallbladder cancer